Global Biopharma Buffer Market Growth 2020-2025
COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.
According to this latest study, the 2020 growth of Biopharma Buffer will have significant change from previous year. By the most conservative estimates of global Biopharma Buffer market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the Biopharma Buffer market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Biopharma Buffer market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Biopharma Buffer, covering the supply chain analysis, impact assessment to the Biopharma Buffer market size growth rate in several scenarios, and the measures to be undertaken by Biopharma Buffer companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Phosphates Type
Acetates Type
TRIS Type
Others
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Research Institution
Pharmaceutical Industry
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Avantor
XZL BIO-TECHNOLOGY
Alfa Aesar (Thermo Fisher)
Lonza
Bio-Rad
Merck
Promega Corporation
BD
Hamilton Company
GE Healthcare
SRL
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Biopharma Buffer consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Biopharma Buffer market by identifying its various subsegments.
Focuses on the key global Biopharma Buffer manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Biopharma Buffer with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Biopharma Buffer submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 What is the Impact of Covid-19 Outbreak On the Biopharma Buffer?
1.8.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.
1.8.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.
1.8.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Biopharma Buffer Market Size in 2020, by Scenario
1.8.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biopharma Buffer Consumption 2015-2025
2.1.2 Biopharma Buffer Consumption CAGR by Region
2.2 Biopharma Buffer Segment by Type
2.2.1 Phosphates Type
2.2.2 Acetates Type
2.2.3 TRIS Type
2.2.4 Others
2.3 Biopharma Buffer Consumption by Type
2.3.1 Global Biopharma Buffer Consumption Market Share by Type (2015-2020)
2.3.2 Global Biopharma Buffer Revenue and Market Share by Type (2015-2020)
2.3.3 Global Biopharma Buffer Sale Price by Type (2015-2020)
2.4 Biopharma Buffer Segment by Application
2.4.1 Research Institution
2.4.2 Pharmaceutical Industry
2.4.3 Others
2.5 Biopharma Buffer Consumption by Application
2.5.1 Global Biopharma Buffer Consumption Market Share by Type (2015-2020)
2.5.2 Global Biopharma Buffer Value and Market Share by Type (2015-2020)
2.5.3 Global Biopharma Buffer Sale Price by Type (2015-2020)
3 Global Biopharma Buffer by Company
3.1 Global Biopharma Buffer Sales Market Share by Company
3.1.1 Global Biopharma Buffer Sales by Company (2018-2020)
3.1.2 Global Biopharma Buffer Sales Market Share by Company (2018-2020)
3.2 Global Biopharma Buffer Revenue Market Share by Company
3.2.1 Global Biopharma Buffer Revenue by Company (2018-2020)
3.2.2 Global Biopharma Buffer Revenue Market Share by Company (2018-2020)
3.3 Global Biopharma Buffer Sale Price by Company
3.4 Global Biopharma Buffer Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Biopharma Buffer Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Biopharma Buffer Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Biopharma Buffer by Regions
4.1 Biopharma Buffer by Regions
4.2 Americas Biopharma Buffer Consumption Growth
4.3 APAC Biopharma Buffer Consumption Growth
4.4 Europe Biopharma Buffer Consumption Growth
4.5 Middle East & Africa Biopharma Buffer Consumption Growth
5 Americas
5.1 Americas Biopharma Buffer Consumption by Countries
5.1.1 Americas Biopharma Buffer Consumption by Countries (2015-2020)
5.1.2 Americas Biopharma Buffer Value by Countries (2015-2020)
5.2 Americas Biopharma Buffer Consumption by Type
5.3 Americas Biopharma Buffer Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Biopharma Buffer Consumption by Regions
6.1.1 APAC Biopharma Buffer Consumption by Regions (2015-2020)
6.1.2 APAC Biopharma Buffer Value by Regions (2015-2020)
6.2 APAC Biopharma Buffer Consumption by Type
6.3 APAC Biopharma Buffer Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Biopharma Buffer by Countries
7.1.1 Europe Biopharma Buffer Consumption by Countries (2015-2020)
7.1.2 Europe Biopharma Buffer Value by Countries (2015-2020)
7.2 Europe Biopharma Buffer Consumption by Type
7.3 Europe Biopharma Buffer Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Biopharma Buffer by Countries
8.1.1 Middle East & Africa Biopharma Buffer Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Biopharma Buffer Value by Countries (2015-2020)
8.2 Middle East & Africa Biopharma Buffer Consumption by Type
8.3 Middle East & Africa Biopharma Buffer Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Biopharma Buffer Distributors
10.3 Biopharma Buffer Customer
11 Global Biopharma Buffer Market Forecast
11.1 Global Biopharma Buffer Consumption Forecast (2021-2025)
11.2 Global Biopharma Buffer Forecast by Regions
11.2.1 Global Biopharma Buffer Forecast by Regions (2021-2025)
11.2.2 Global Biopharma Buffer Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Biopharma Buffer Forecast by Type
11.8 Global Biopharma Buffer Forecast by Application
12 Key Players Analysis
12.1 Avantor
12.1.1 Company Information
12.1.2 Biopharma Buffer Product Offered
12.1.3 Avantor Biopharma Buffer Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Avantor Latest Developments
12.2 XZL BIO-TECHNOLOGY
12.2.1 Company Information
12.2.2 Biopharma Buffer Product Offered
12.2.3 XZL BIO-TECHNOLOGY Biopharma Buffer Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 XZL BIO-TECHNOLOGY Latest Developments
12.3 Alfa Aesar (Thermo Fisher)
12.3.1 Company Information
12.3.2 Biopharma Buffer Product Offered
12.3.3 Alfa Aesar (Thermo Fisher) Biopharma Buffer Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Alfa Aesar (Thermo Fisher) Latest Developments
12.4 Lonza
12.4.1 Company Information
12.4.2 Biopharma Buffer Product Offered
12.4.3 Lonza Biopharma Buffer Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Lonza Latest Developments
12.5 Bio-Rad
12.5.1 Company Information
12.5.2 Biopharma Buffer Product Offered
12.5.3 Bio-Rad Biopharma Buffer Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Bio-Rad Latest Developments
12.6 Merck
12.6.1 Company Information
12.6.2 Biopharma Buffer Product Offered
12.6.3 Merck Biopharma Buffer Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Merck Latest Developments
12.7 Promega Corporation
12.7.1 Company Information
12.7.2 Biopharma Buffer Product Offered
12.7.3 Promega Corporation Biopharma Buffer Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Promega Corporation Latest Developments
12.8 BD
12.8.1 Company Information
12.8.2 Biopharma Buffer Product Offered
12.8.3 BD Biopharma Buffer Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 BD Latest Developments
12.9 Hamilton Company
12.9.1 Company Information
12.9.2 Biopharma Buffer Product Offered
12.9.3 Hamilton Company Biopharma Buffer Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Hamilton Company Latest Developments
12.10 GE Healthcare
12.10.1 Company Information
12.10.2 Biopharma Buffer Product Offered
12.10.3 GE Healthcare Biopharma Buffer Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 GE Healthcare Latest Developments
12.11 SRL
12.11.1 Company Information
12.11.2 Biopharma Buffer Product Offered
12.11.3 SRL Biopharma Buffer Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 SRL Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Biopharma Buffer Market Size in 2020, by Scenario
Table 2. COVID-19: Measures to be Undertaken by Biopharma Buffer Companies
Table 3. Research Methodology
Table 4. Data Source
Table 5. Biopharma Buffer Consumption CAGR by Region 2015-2025 ($ Millions)
Table 6. Major Players of Phosphates Type
Table 7. Major Players of Acetates Type
Table 8. Major Players of TRIS Type
Table 9. Major Players of Others
Table 10. Global Consumption Sales by Type (2015-2020)
Table 11. Global Biopharma Buffer Consumption Market Share by Type (2015-2020)
Table 12. Global Biopharma Buffer Revenue by Type (2015-2020) ($ million)
Table 13. Global Biopharma Buffer Value Market Share by Type (2015-2020) ($ Millions)
Table 14. Global Biopharma Buffer Sale Price by Type (2015-2020)
Table 15. Global Consumption Sales by Application (2015-2020)
Table 16. Global Biopharma Buffer Consumption Market Share by Application (2015-2020)
Table 17. Global Biopharma Buffer Value by Application (2015-2020)
Table 18. Global Biopharma Buffer Value Market Share by Application (2015-2020)
Table 19. Global Biopharma Buffer Sale Price by Application (2015-2020)
Table 20. Global Biopharma Buffer Sales by Company (2017-2019) (KL)
Table 21. Global Biopharma Buffer Sales Market Share by Company (2017-2019)
Table 22. Global Biopharma Buffer Revenue by Company (2017-2019) ($ Millions)
Table 23. Global Biopharma Buffer Revenue Market Share by Company (2017-2019)
Table 24. Global Biopharma Buffer Sale Price by Company (2017-2019)
Table 25. Global Biopharma Buffer Manufacturing Base Distribution and Sales Area by Manufacturers
Table 26. Players Biopharma Buffer Products Offered
Table 27. Biopharma Buffer Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 28. Global Biopharma Buffer Consumption by Regions 2015-2020 (KL)
Table 29. Global Biopharma Buffer Consumption Market Share by Regions 2015-2020
Table 30. Global Biopharma Buffer Value by Regions 2015-2020 ($ Millions)
Table 31. Global Biopharma Buffer Value Market Share by Regions 2015-2020
Table 32. Americas Biopharma Buffer Consumption by Countries (2015-2020) (KL)
Table 33. Americas Biopharma Buffer Consumption Market Share by Countries (2015-2020)
Table 34. Americas Biopharma Buffer Value by Countries (2015-2020) ($ Millions)
Table 35. Americas Biopharma Buffer Value Market Share by Countries (2015-2020)
Table 36. Americas Biopharma Buffer Consumption by Type (2015-2020) (KL)
Table 37. Americas Biopharma Buffer Consumption Market Share by Type (2015-2020)
Table 38. Americas Biopharma Buffer Consumption by Application (2015-2020) (KL)
Table 39. Americas Biopharma Buffer Consumption Market Share by Application (2015-2020)
Table 40. APAC Biopharma Buffer Consumption by Countries (2015-2020) (KL)
Table 41. APAC Biopharma Buffer Consumption Market Share by Countries (2015-2020)
Table 42. APAC Biopharma Buffer Value by Regions (2015-2020) ($ Millions)
Table 43. APAC Biopharma Buffer Value Market Share by Regions (2015-2020)
Table 44. APAC Biopharma Buffer Consumption by Type (2015-2020) (KL)
Table 45. APAC Biopharma Buffer Consumption Market Share by Type (2015-2020)
Table 46. APAC Biopharma Buffer Consumption by Application (2015-2020) (KL)
Table 47. APAC Biopharma Buffer Consumption Market Share by Application (2015-2020)
Table 48. Europe Biopharma Buffer Consumption by Countries (2015-2020) (KL)
Table 49. Europe Biopharma Buffer Consumption Market Share by Countries (2015-2020)
Table 50. Europe Biopharma Buffer Value by Countries (2015-2020) ($ Millions)
Table 51. Europe Biopharma Buffer Value Market Share by Countries (2015-2020)
Table 52. Europe Biopharma Buffer Consumption by Type (2015-2020) (KL)
Table 53. Europe Biopharma Buffer Consumption Market Share by Type (2015-2020)
Table 54. Europe Biopharma Buffer Consumption by Application (2015-2020) (KL)
Table 55. Europe Biopharma Buffer Consumption Market Share by Application (2015-2020)
Table 56. Middle East & Africa Biopharma Buffer Consumption by Countries (2015-2020) (KL)
Table 57. Middle East & Africa Biopharma Buffer Consumption Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Biopharma Buffer Value by Countries (2015-2020) ($ Millions)
Table 59. Middle East & Africa Biopharma Buffer Value Market Share by Countries (2015-2020)
Table 60. Middle East & Africa Biopharma Buffer Consumption by Type (2015-2020) (KL)
Table 61. Middle East & Africa Biopharma Buffer Consumption Market Share by Type (2015-2020)
Table 62. Middle East & Africa Biopharma Buffer Consumption by Application (2015-2020) (KL)
Table 63. Middle East & Africa Biopharma Buffer Consumption Market Share by Application (2015-2020)
Table 64. Biopharma Buffer Distributors List
Table 65. Biopharma Buffer Customer List
Table 66. Global Biopharma Buffer Consumption Forecast by Countries (2021-2025) (KL)
Table 67. Global Biopharma Buffer Consumption Market Forecast by Regions
Table 68. Global Biopharma Buffer Value Forecast by Countries (2021-2025) ($ Millions)
Table 69. Global Biopharma Buffer Value Market Share Forecast by Regions
Table 70. Global Biopharma Buffer Consumption Forecast by Type (2021-2025) (KL)
Table 71. Global Biopharma Buffer Consumption Market Share Forecast by Type (2021-2025)
Table 72. Global Biopharma Buffer Value Forecast by Type (2021-2025) ($ Millions)
Table 73. Global Biopharma Buffer Value Market Share Forecast by Type (2021-2025)
Table 74. Global Biopharma Buffer Consumption Forecast by Application (2021-2025) (KL)
Table 75. Global Biopharma Buffer Consumption Market Share Forecast by Application (2021-2025)
Table 76. Global Biopharma Buffer Value Forecast by Application (2021-2025) ($ Millions)
Table 77. Global Biopharma Buffer Value Market Share Forecast by Application (2021-2025)
Table 78. Avantor Product Offered
Table 79. Avantor Biopharma Buffer Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2020E)
Table 80. Avantor Main Business
Table 81. Avantor Latest Developments
Table 82. Avantor Basic Information, Company Total Revenue (in $ million), Biopharma Buffer Manufacturing Base, Sales Area and Its Competitors
Table 83. XZL BIO-TECHNOLOGY Product Offered
Table 84. XZL BIO-TECHNOLOGY Biopharma Buffer Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2020E)
Table 85. XZL BIO-TECHNOLOGY Main Business
Table 86. XZL BIO-TECHNOLOGY Latest Developments
Table 87. XZL BIO-TECHNOLOGY Basic Information, Company Total Revenue (in $ million), Biopharma Buffer Manufacturing Base, Sales Area and Its Competitors
Table 88. Alfa Aesar (Thermo Fisher) Product Offered
Table 89. Alfa Aesar (Thermo Fisher) Biopharma Buffer Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2020E)
Table 90. Alfa Aesar (Thermo Fisher) Main Business
Table 91. Alfa Aesar (Thermo Fisher) Latest Developments
Table 92. Alfa Aesar (Thermo Fisher) Basic Information, Company Total Revenue (in $ million), Biopharma Buffer Manufacturing Base, Sales Area and Its Competitors
Table 93. Lonza Product Offered
Table 94. Lonza Biopharma Buffer Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2020E)
Table 95. Lonza Main Business
Table 96. Lonza Latest Developments
Table 97. Lonza Basic Information, Company Total Revenue (in $ million), Biopharma Buffer Manufacturing Base, Sales Area and Its Competitors
Table 98. Bio-Rad Product Offered
Table 99. Bio-Rad Biopharma Buffer Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2020E)
Table 100. Bio-Rad Main Business
Table 101. Bio-Rad Latest Developments
Table 102. Bio-Rad Basic Information, Company Total Revenue (in $ million), Biopharma Buffer Manufacturing Base, Sales Area and Its Competitors
Table 103. Merck Product Offered
Table 104. Merck Biopharma Buffer Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2020E)
Table 105. Merck Main Business
Table 106. Merck Latest Developments
Table 107. Merck Basic Information, Company Total Revenue (in $ million), Biopharma Buffer Manufacturing Base, Sales Area and Its Competitors
Table 108. Promega Corporation Product Offered
Table 109. Promega Corporation Basic Information, Company Total Revenue (in $ million), Biopharma Buffer Manufacturing Base, Sales Area and Its Competitors
Table 110. Promega Corporation Main Business
Table 111. Promega Corporation Latest Developments
Table 112. Promega Corporation Biopharma Buffer Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2020E)
Table 113. BD Product Offered
Table 114. BD Biopharma Buffer Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2020E)
Table 115. BD Main Business
Table 116. BD Latest Developments
Table 117. BD Basic Information, Company Total Revenue (in $ million), Biopharma Buffer Manufacturing Base, Sales Area and Its Competitors
Table 118. Hamilton Company Product Offered
Table 119. Hamilton Company Biopharma Buffer Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2020E)
Table 120. Hamilton Company Main Business
Table 121. Hamilton Company Latest Developments
Table 122. Hamilton Company Basic Information, Company Total Revenue (in $ million), Biopharma Buffer Manufacturing Base, Sales Area and Its Competitors
Table 123. GE Healthcare Product Offered
Table 124. GE Healthcare Biopharma Buffer Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2020E)
Table 125. GE Healthcare Main Business
Table 126. GE Healthcare Latest Developments
Table 127. GE Healthcare Basic Information, Company Total Revenue (in $ million), Biopharma Buffer Manufacturing Base, Sales Area and Its Competitors
Table 128. SRL Product Offered
Table 129. SRL Biopharma Buffer Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2020E)
Table 130. SRL Main Business
Table 131. SRL Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 132. SRL Latest Developments
List of Figures
Figure 1. Picture of Biopharma Buffer
Figure 2. Biopharma Buffer Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Biopharma Buffer Consumption Growth Rate 2015-2025 (KL)
Figure 5. Global Biopharma Buffer Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Phosphates Type
Figure 7. Product Picture of Acetates Type
Figure 8. Product Picture of TRIS Type
Figure 9. Product Picture of Others
Figure 10. Global Biopharma Buffer Consumption Market Share by Type (2015-2020)
Figure 11. Global Biopharma Buffer Value Market Share by Type (2015-2020)
Figure 12. Biopharma Buffer Consumed in Research Institution
Figure 13. Global Biopharma Buffer Market: Research Institution (2015-2020) (KL)
Figure 14. Global Biopharma Buffer Market: Research Institution (2015-2020) ($ Millions)
Figure 15. Biopharma Buffer Consumed in Pharmaceutical Industry
Figure 16. Global Biopharma Buffer Market: Pharmaceutical Industry (2015-2020) (KL)
Figure 17. Global Biopharma Buffer Market: Pharmaceutical Industry (2015-2020) ($ Millions)
Figure 18. Biopharma Buffer Consumed in Others
Figure 19. Global Biopharma Buffer Market: Others (2015-2020) (KL)
Figure 20. Global Biopharma Buffer Market: Others (2015-2020) ($ Millions)
Figure 21. Global Biopharma Buffer Consumption Market Share by Application (2015-2020)
Figure 22. Global Biopharma Buffer Value Market Share by Application (2015-2020)
Figure 23. Global Biopharma Buffer Sales Market Share by Company in 2017
Figure 24. Global Biopharma Buffer Sales Market Share by Company in 2019
Figure 25. Global Biopharma Buffer Revenue Market Share by Company in 2017
Figure 26. Global Biopharma Buffer Revenue Market Share by Company in 2019
Figure 27. Global Biopharma Buffer Sale Price by Company in 2019
Figure 28. Global Biopharma Buffer Consumption Market Share by Regions 2015-2020
Figure 29. Global Biopharma Buffer Value Market Share by Regions 2015-2020
Figure 30. Americas Biopharma Buffer Consumption 2015-2020 (KL)
Figure 31. Americas Biopharma Buffer Value 2015-2020 ($ Millions)
Figure 32. APAC Biopharma Buffer Consumption 2015-2020 (KL)
Figure 33. APAC Biopharma Buffer Value 2015-2020 ($ Millions)
Figure 34. Europe Biopharma Buffer Consumption 2015-2020 (KL)
Figure 35. Europe Biopharma Buffer Value 2015-2020 ($ Millions)
Figure 36. Middle East & Africa Biopharma Buffer Consumption 2015-2020 (KL)
Figure 37. Middle East & Africa Biopharma Buffer Value 2015-2020 ($ Millions)
Figure 38. Americas Biopharma Buffer Consumption Market Share by Countries in 2019
Figure 39. Americas Biopharma Buffer Value Market Share by Countries in 2019
Figure 40. Americas Biopharma Buffer Consumption Market Share by Type in 2019
Figure 41. Americas Biopharma Buffer Consumption Market Share by Application in 2019
Figure 42. United States Biopharma Buffer Consumption Growth 2015-2020 (KL)
Figure 43. United States Biopharma Buffer Value Growth 2015-2020 ($ Millions)
Figure 44. Canada Biopharma Buffer Consumption Growth 2015-2020 (KL)
Figure 45. Canada Biopharma Buffer Value Growth 2015-2020 ($ Millions)
Figure 46. Mexico Biopharma Buffer Consumption Growth 2015-2020 (KL)
Figure 47. Mexico Biopharma Buffer Value Growth 2015-2020 ($ Millions)
Figure 48. APAC Biopharma Buffer Consumption Market Share by Countries in 2019
Figure 49. APAC Biopharma Buffer Value Market Share by Regions in 2019
Figure 50. APAC Biopharma Buffer Consumption Market Share by Type in 2019
Figure 51. APAC Biopharma Buffer Consumption Market Share by Application in 2019
Figure 52. China Biopharma Buffer Consumption Growth 2015-2020 (KL)
Figure 53. China Biopharma Buffer Value Growth 2015-2020 ($ Millions)
Figure 54. Japan Biopharma Buffer Consumption Growth 2015-2020 (KL)
Figure 55. Japan Biopharma Buffer Value Growth 2015-2020 ($ Millions)
Figure 56. Korea Biopharma Buffer Consumption Growth 2015-2020 (KL)
Figure 57. Korea Biopharma Buffer Value Growth 2015-2020 ($ Millions)
Figure 58. Southeast Asia Biopharma Buffer Consumption Growth 2015-2020 (KL)
Figure 59. Southeast Asia Biopharma Buffer Value Growth 2015-2020 ($ Millions)
Figure 60. India Biopharma Buffer Consumption Growth 2015-2020 (KL)
Figure 61. India Biopharma Buffer Value Growth 2015-2020 ($ Millions)
Figure 62. Australia Biopharma Buffer Consumption Growth 2015-2020 (KL)
Figure 63. Australia Biopharma Buffer Value Growth 2015-2020 ($ Millions)
Figure 64. Europe Biopharma Buffer Consumption Market Share by Countries in 2019
Figure 65. Europe Biopharma Buffer Value Market Share by Countries in 2019
Figure 66. Europe Biopharma Buffer Consumption Market Share by Type in 2019
Figure 67. Europe Biopharma Buffer Consumption Market Share by Application in 2019
Figure 68. Germany Biopharma Buffer Consumption Growth 2015-2020 (KL)
Figure 69. Germany Biopharma Buffer Value Growth 2015-2020 ($ Millions)
Figure 70. France Biopharma Buffer Consumption Growth 2015-2020 (KL)
Figure 71. France Biopharma Buffer Value Growth 2015-2020 ($ Millions)
Figure 72. UK Biopharma Buffer Consumption Growth 2015-2020 (KL)
Figure 73. UK Biopharma Buffer Value Growth 2015-2020 ($ Millions)
Figure 74. Italy Biopharma Buffer Consumption Growth 2015-2020 (KL)
Figure 75. Italy Biopharma Buffer Value Growth 2015-2020 ($ Millions)
Figure 76. Russia Biopharma Buffer Consumption Growth 2015-2020 (KL)
Figure 77. Russia Biopharma Buffer Value Growth 2015-2020 ($ Millions)
Figure 78. Middle East & Africa Biopharma Buffer Consumption Market Share by Countries in 2019
Figure 79. Middle East & Africa Biopharma Buffer Value Market Share by Countries in 2019
Figure 80. Middle East & Africa Biopharma Buffer Consumption Market Share by Type in 2019
Figure 81. Middle East & Africa Biopharma Buffer Consumption Market Share by Application in 2019
Figure 82. Egypt Biopharma Buffer Consumption Growth 2015-2020 (KL)
Figure 83. Egypt Biopharma Buffer Value Growth 2015-2020 ($ Millions)
Figure 84. South Africa Biopharma Buffer Consumption Growth 2015-2020 (KL)
Figure 85. South Africa Biopharma Buffer Value Growth 2015-2020 ($ Millions)
Figure 86. Israel Biopharma Buffer Consumption Growth 2015-2020 (KL)
Figure 87. Israel Biopharma Buffer Value Growth 2015-2020 ($ Millions)
Figure 88. Turkey Biopharma Buffer Consumption Growth 2015-2020 (KL)
Figure 89. Turkey Biopharma Buffer Value Growth 2015-2020 ($ Millions)
Figure 90. GCC Countries Biopharma Buffer Consumption Growth 2015-2020 (KL)
Figure 91. GCC Countries Biopharma Buffer Value Growth 2015-2020 ($ Millions)
Figure 92. Global Biopharma Buffer Consumption Growth Rate Forecast (2021-2025) (KL)
Figure 93. Global Biopharma Buffer Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 94. Americas Biopharma Buffer Consumption 2021-2025 (KL)
Figure 95. Americas Biopharma Buffer Value 2021-2025 ($ Millions)
Figure 96. APAC Biopharma Buffer Consumption 2021-2025 (KL)
Figure 97. APAC Biopharma Buffer Value 2021-2025 ($ Millions)
Figure 98. Europe Biopharma Buffer Consumption 2021-2025 (KL)
Figure 99. Europe Biopharma Buffer Value 2021-2025 ($ Millions)
Figure 100. Middle East & Africa Biopharma Buffer Consumption 2021-2025 (KL)
Figure 101. Middle East & Africa Biopharma Buffer Value 2021-2025 ($ Millions)
Figure 102. United States Biopharma Buffer Consumption 2021-2025 (KL)
Figure 103. United States Biopharma Buffer Value 2021-2025 ($ Millions)
Figure 104. Canada Biopharma Buffer Consumption 2021-2025 (KL)
Figure 105. Canada Biopharma Buffer Value 2021-2025 ($ Millions)
Figure 106. Mexico Biopharma Buffer Consumption 2021-2025 (KL)
Figure 107. Mexico Biopharma Buffer Value 2021-2025 ($ Millions)
Figure 108. Brazil Biopharma Buffer Consumption 2021-2025 (KL)
Figure 109. Brazil Biopharma Buffer Value 2021-2025 ($ Millions)
Figure 110. China Biopharma Buffer Consumption 2021-2025 (KL)
Figure 111. China Biopharma Buffer Value 2021-2025 ($ Millions)
Figure 112. Japan Biopharma Buffer Consumption 2021-2025 (KL)
Figure 113. Japan Biopharma Buffer Value 2021-2025 ($ Millions)
Figure 114. Korea Biopharma Buffer Consumption 2021-2025 (KL)
Figure 115. Korea Biopharma Buffer Value 2021-2025 ($ Millions)
Figure 116. Southeast Asia Biopharma Buffer Consumption 2021-2025 (KL)
Figure 117. Southeast Asia Biopharma Buffer Value 2021-2025 ($ Millions)
Figure 118. India Biopharma Buffer Consumption 2021-2025 (KL)
Figure 119. India Biopharma Buffer Value 2021-2025 ($ Millions)
Figure 120. Australia Biopharma Buffer Consumption 2021-2025 (KL)
Figure 121. Australia Biopharma Buffer Value 2021-2025 ($ Millions)
Figure 122. Germany Biopharma Buffer Consumption 2021-2025 (KL)
Figure 123. Germany Biopharma Buffer Value 2021-2025 ($ Millions)
Figure 124. France Biopharma Buffer Consumption 2021-2025 (KL)
Figure 125. France Biopharma Buffer Value 2021-2025 ($ Millions)
Figure 126. UK Biopharma Buffer Consumption 2021-2025 (KL)
Figure 127. UK Biopharma Buffer Value 2021-2025 ($ Millions)
Figure 128. Italy Biopharma Buffer Consumption 2021-2025 (KL)
Figure 129. Italy Biopharma Buffer Value 2021-2025 ($ Millions)
Figure 130. Russia Biopharma Buffer Consumption 2021-2025 (KL)
Figure 131. Russia Biopharma Buffer Value 2021-2025 ($ Millions)
Figure 132. Spain Biopharma Buffer Consumption 2021-2025 (KL)
Figure 133. Spain Biopharma Buffer Value 2021-2025 ($ Millions)
Figure 134. Egypt Biopharma Buffer Consumption 2021-2025 (KL)
Figure 135. Egypt Biopharma Buffer Value 2021-2025 ($ Millions)
Figure 136. South Africa Biopharma Buffer Consumption 2021-2025 (KL)
Figure 137. South Africa Biopharma Buffer Value 2021-2025 ($ Millions)
Figure 138. Israel Biopharma Buffer Consumption 2021-2025 (KL)
Figure 139. Israel Biopharma Buffer Value 2021-2025 ($ Millions)
Figure 140. Turkey Biopharma Buffer Consumption 2021-2025 (KL)
Figure 141. Turkey Biopharma Buffer Value 2021-2025 ($ Millions)
Figure 142. GCC Countries Biopharma Buffer Consumption 2021-2025 (KL)
Figure 143. GCC Countries Biopharma Buffer Value 2021-2025 ($ Millions)
Figure 144. Avantor Biopharma Buffer Market Share (2018-2020)
Figure 145. XZL BIO-TECHNOLOGY Biopharma Buffer Market Share (2018-2020)
Figure 146. Alfa Aesar (Thermo Fisher) Biopharma Buffer Market Share (2018-2020)
Figure 147. Lonza Biopharma Buffer Market Share (2018-2020)
Figure 148. Bio-Rad Biopharma Buffer Market Share (2018-2020)
Figure 149. Merck Biopharma Buffer Market Share (2018-2020)
Figure 150. Promega Corporation Biopharma Buffer Market Share (2018-2020)
Figure 151. BD Biopharma Buffer Market Share (2018-2020)
Figure 152. Hamilton Company Biopharma Buffer Market Share (2018-2020)
Figure 153. GE Healthcare Biopharma Buffer Market Share (2018-2020)
Figure 154. SRL Biopharma Buffer Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets